Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
KKS Venture Management is a London-based strategic advisory and investment management firm specializing in the life sciences and biotechnology sectors. Founded in 2002 by Shinichi Tamura, the founder and former CEO of Sosei Heptares (now Nxera Pharma), the firm provides high-level management consultancy and corporate development services. KKS Venture Management focuses on bridging the gap between the Japanese and international healthcare markets, leveraging deep expertise in drug discovery and global business development. The firm has played a pivotal role in the strategic growth of several biotech entities, most notably through its long-standing association with the evolution of Sosei into a global biopharmaceutical leader. It continues to support innovation in the healthcare space through strategic investments and advisory roles for emerging life science companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on KKS Venture Management.